Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Arcus Biosciences
company
Funding Round
Post-IPO Equity
Money Raised
$ 220.35M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Gilead Sciences | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Nov 13, 2017 | Series C | $ 107M | Aisling Capital,Biotechnology Value Fund,etc. | Detail |
| May 1, 2015 | Series A | $ 49.70M | Celgene,The Column Group | Detail |
| Sep 1, 2016 | Series B | $ 70M | Celgene,Droia Ventures,etc. | Detail |
| May 28, 2020 | Post-IPO Equity | $ 200M | Gilead Sciences | Detail |
| Mar 14, 2018 | IPO | $ 120M | Detail |
